CAS RN: 191729-43-8

Tenacissoside G

Product Availability

Choose a grade to view its available package options.

6 package records0 with current stock2 grade groups
Batch No.PackageAvailabilityLead TimeInquiry
Batchno.20250331 20mg Out of stock 5-7 business days Inquiry
Batch No.PackageAvailabilityLead TimeInquiry
Batchno.20251128 10mg Out of stock Inquiry
Batchno.20250124 1mg Out of stock Inquiry
Batchno.20260501 25mg Out of stock Inquiry
Batchno.20260406 50mg Out of stock Inquiry
Batchno.20250418 5mg Out of stock Inquiry
  • Product code: starshine_CAS191729-43-8
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

191729-43-8 / [(1S,3R,6R,7S,8S,9S,10S,11S,14S,16S)-6-acetyl-8-acetyloxy-14-[(2R,4R,5R,6R)-5-[(2S,3R,4R,5R,6R)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-7,11-dimethyl-2-oxapentacyclo[8.8.0.01,3.03,7.011,16]octadecan-9-yl] (E)-2-methylbut-2-enoate

Standard CAS: 191729-43-8 Multi CAS: No

Basic Information

CAS
191729-43-8
Multi CAS
No
Molecular Formula
C42H64O14
Molecular Weight
792.900000
Exact Mass
792.429607
SMILES
C/C=C(\C)/C(=O)O[C@H]1[C@@H]2[C@]3(CC[C@@H](C[C@@H]3CC[C@@]24[C@@]5(O4)CC[C@H]([C@]5([C@@H]1OC(=O)C)C)C(=O)C)O[C@H]6C[C@H]([C@@H]([C@H](O6)C)O[C@H]7[C@@H]([C@@H]([C@@H]([C@H](O7)C)O)OC)O)OC)C
InChI
InChI=1S/C42H64O14/c1-11-20(2)37(47)54-34-35-39(7)15-13-26(53-29-19-28(48-9)32(23(5)50-29)55-38-31(46)33(49-10)30(45)22(4)51-38)18-25(39)12-16-41(35)42(56-41)17-14-27(21(3)43)40(42,8)36(34)52-24(6)44/h11,22-23,25-36,38,45-46H,12-19H2,1-10H3/b20-11+/t22-,23-,25+,26+,27+,28-,29+,30-,31-,32-,33-,34+,35-,36-,38+,39+,40+,41+,42-/m1/s1
InChIKey
OHDJGUWKOIBIKY-SGFNNURDSA-N

Computed Properties

Structural Parameters

Heavy atom count
56
Fraction Csp3
0.88
Rotatable bonds
10
H-bond acceptors
14
H-bond donors
2
Molar refractivity
197.74
TPSA
178.04

LogP / Solubility

WLOGP
3.94
MLOGP
3.54
XLogP3
3.1
Consensus LogP
3.53
Log S (ESOL)
-6.58
Class (ESOL)
Insoluble
Log S (Ali)
-8.91
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-9.29
Class (SILICOS-IT)
Insoluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-4.76

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.17
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
10

Get In Touch

Contact Us